Who owns BRIGHT MINDS BIOSCIENCES INC?
- Ticker: DRUG
- CUSIP Number: 10919w405
Tip: Access positions for across all investors
Analyze quarterly positions in Bright Minds Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bright Minds Biosciences stock
Who bought or sold BRIGHT MINDS BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Henderson Group | 1.3M | $94M | 12% | Mar 2026 |
|
| Cormorant Asset Management | 1.1M | $77M | 0% | Mar 2026 |
|
| BlackRock | 622k | $45M | 58% | Mar 2026 |
|
| Vivo Capital | 557k | $41M | 11% | Mar 2026 |
|
| Braidwell | 540k | $39M | 66% | Mar 2026 |
|
| Vestal Point Capital | 492k | $36M | 100% | Mar 2026 |
|
| Adage Capital Partners GP | 396k | $31M | 0% | Dec 2025 |
|
| Perceptive Advisors | 378k | $28M | -16% | Mar 2026 |
|
| Balyasny Asset Management | 297k | $22M | 32% | Mar 2026 |
|
| Deerfield Management Company | 283k | $21M | 100% | Mar 2026 |
|
| Driehaus Capital Management | 270k | $21M | 100% | Dec 2025 |
|
| RA Capital Management | 265k | $19M | 100% | Mar 2026 |
|
| Dr. Jeffrey R. Jay, M.D. | 220k | $16M | 100% | Mar 2026 |
|
| MPM Oncology Impact Management | 212k | $16M | -8% | Mar 2026 |
|
| Ikarian Capital | 167k | $12M | 5% | Mar 2026 |
|
| Morgan Stanley | 133k | $9.7M | 0% | Mar 2026 |
|
| Seven Grand Managers | 120k | $8.8M | 140% | Mar 2026 |
|
| Longwood Capital Partners | 112k | $8.2M | 33% | Mar 2026 |
|
| Eventide Asset Management | 103k | $8.0M | 100% | Dec 2025 |
|
| Geode Capital Management | 89k | $6.5M | 40% | Mar 2026 |
|
| Sio Capital Management | 82k | $6.4M | -57% | Dec 2025 |
|
| State Street Corporation | 77k | $6.0M | 13% | Dec 2025 |
|
| Goldman Sachs Group | 74k | $5.4M | 53% | Mar 2026 |
|
| Vanguard Portfolio Management | 61k | $4.4M | 100% | Mar 2026 |
|
| Walleye Trading Advisors | 54k | $3.9M | 108% | Mar 2026 |
|
| Millennium Management | 53k | $3.9M | -73% | Mar 2026 |
|
| Boothbay Fund Management | 51k | $3.7M | 8% | Mar 2026 |
|
| Ameriprise Financial | 50k | $3.7M | 100% | Mar 2026 |
|
| Vanguard Group | 49k | $3.8M | 8% | Dec 2025 |
|
| Superstring Capital Management | 47k | $3.7M | -12% | Dec 2025 |
|
| Woodline Partners | 46k | $3.3M | 100% | Mar 2026 |
|
| OrbiMed Advisors | 40k | $2.9M | 100% | Mar 2026 |
|
| Artia Global Partners | 38k | $2.8M | 15% | Mar 2026 |
|
| ADAR1 Capital Management | 34k | $2.5M | 869% | Mar 2026 |
|
| KVP Capital Advisors | 32k | $2.3M | 100% | Mar 2026 |
|
| Northern Trust | 26k | $2.0M | -6% | Dec 2025 |
|
| Bank of America Corporation | 19k | $1.4M | 100% | Mar 2026 |
|
| Platinum Investment Mangement | 19k | $1.4M | -12% | Mar 2026 |
|
| D. E. Shaw & Co | 15k | $1.1M | 294% | Mar 2026 |
|
| Wellington Management Company | 14k | $1.1M | 100% | Dec 2025 |
|
| UBS Group | 13k | $969k | -4% | Mar 2026 |
|
| Bank of New York Mellon | 13k | $967k | 33% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 13k | $966k | -56% | Mar 2026 |
|
| AdvisorShares Investments | 13k | $920k | 27% | Mar 2026 |
|
| Charles Schwab Investment Management | 13k | $973k | 7% | Dec 2025 |
|
| Sei Investments | 11k | $816k | 100% | Mar 2026 |
|
| Ghisallo Capital Management | 11k | $803k | 100% | Mar 2026 |
|
| Barclays | 9.7k | $754k | 47% | Dec 2025 |
|
| Eudaimonia Asset Management | 9.2k | $671k | 100% | Mar 2026 |
|
| Nuveen | 8.3k | $608k | 39% | Mar 2026 |
|
| Rhumbline Advisers | 7.8k | $566k | 31% | Mar 2026 |
|
| Trexquant Investment | 7.5k | $544k | 100% | Mar 2026 |
|
| LPL Financial | 6.5k | $474k | 15% | Mar 2026 |
|
| Jane Street | 6.4k | $467k | -29% | Mar 2026 |
|
| Seven Fleet Capital Management | 6.4k | $467k | 100% | Mar 2026 |
|
| Invesco | 6.3k | $459k | 50% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 6.3k | $457k | 47% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 6.1k | $442k | 100% | Mar 2026 |
|
| Marshall Wace | 4.6k | $359k | 100% | Dec 2025 |
|
| DnB NOR Asset Management AS | 4.4k | $324k | 100% | Mar 2026 |
|
| Florida State Board of Administration | 3.8k | $276k | 0% | Mar 2026 |
|
| Mirae Asset Global Etfs Holdings | 3.3k | $238k | 40% | Mar 2026 |
|
| Vanguard Global Advisers | 3.1k | $223k | 100% | Mar 2026 |
|
| MetLife Investment Advisors | 2.9k | $228k | 0% | Dec 2025 |
|
| Virtu Financial | 2.9k | $226k | 100% | Dec 2025 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 2.7k | $197k | 200% | Mar 2026 |
|
| New York State Common Retirement Fund | 2.6k | $190k | 0% | Mar 2026 |
|
| Wells Fargo & Company | 2.5k | $185k | -54% | Mar 2026 |
|
| Persistent Asset Partners | 2.3k | $169k | 100% | Mar 2026 |
|
| Aquatic Capital Management | 2.0k | $149k | 100% | Mar 2026 |
|
| Police & Firemen's Retirement System of New Jersey | 2.0k | $149k | 35% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 1.6k | $115k | -94% | Mar 2026 |
|
| FMR | 1.1k | $87k | 71% | Dec 2025 |
|
| Tower Research Capital | 1.1k | $84k | 299% | Dec 2025 |
|
| Russell Investments | 882.00 | $64k | -6% | Mar 2026 |
|
| Legal & General Group | 616.00 | $45k | 13% | Mar 2026 |
|
| China Universal Asset Management | 500.00 | $37k | 100% | Mar 2026 |
|
| Summit Investment Advisors | 470.00 | $34k | 0% | Mar 2026 |
|
| Royal Bank of Canada | 406.00 | $30k | 162% | Mar 2026 |
|
| California State Teachers Retirement System | 380.00 | $28k | 23% | Mar 2026 |
|
| Advisor Group Holdings | 371.00 | $29k | 100% | Dec 2025 |
|
| Citigroup | 297.00 | $22k | 100% | Mar 2026 |
|
| Goss Wealth Management | 250.00 | $18k | 400% | Mar 2026 |
|
| Global Retirement Partners | 100.00 | $7.8k | -50% | Dec 2025 |
|
| Sterling Capital Management | 45.00 | $3.3k | 50% | Mar 2026 |
|
| GAMMA Investing | 33.00 | $2.4k | 100% | Mar 2026 |
|
| CWM | 10.00 | $1.0k | 67% | Dec 2025 |
|
| Bell Investment Advisors | 6.00 | $438.000000 | 100% | Mar 2026 |
|
| SBI Securities | 5.00 | $365.000000 | 0% | Mar 2026 |
|
| Twin Peaks Wealth Advisors | 1.00 | $73.000000 | 100% | Mar 2026 |
|
| MAI Wealth Advisors | 1.00 | $73.000000 | 100% | Mar 2026 |
|
Who sold out of Bright Minds Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Stempoint Capital | Dec 2025 | 97k | $7.6M |
| Commodore Capital | Dec 2025 | 19k | $1.5M |
| Jpmorgan Chase & Co | Sep 2025 | 5.3k | $319k |
| Renaissance Technologies | Sep 2025 | 3.5k | $212k |
| Two Sigma Investments | Dec 2025 | 2.6k | $203k |
| Amalgamated Bank | Dec 2025 | 159.00 | $12k |
| Farther Finance Advisors | Dec 2025 | 39.00 | $3.0k |